Literature DB >> 3142880

Tissue-specific expression of apolipoprotein A-I (ApoA-I) is regulated by the 5'-flanking region of the human ApoA-I gene.

K Higuchi1, S W Law, J M Hoeg, U K Schumacher, N Meglin, H B Brewer.   

Abstract

We have isolated and characterized a 2.5-kilobase pairs genomic DNA fragment which includes the 5'-flanking region and the first and second exons of the human apolipoprotein (apo) A-I gene. The major transcriptional start site was determined by primer extension analysis and is 235 base pairs (bp) upstream from the AUG translational start codon in liver and 234 bp upstream in the intestine. TATA box-like and CAT box-like sequences and two GC box sequences are present in the intestine 30, 108, 220, and 440 bp upstream, respectively, from the transcriptional start site. Fragments of 570 bp (-487 to +71) and 2.15 kilobase pairs (-2067 to +99) containing the 5'-flanking region of the apoA-I gene were fused upstream to the bacterial chloramphenicol acetyltransferase (CAT) gene. These constructs, designated pA-I(0.6)CAT and pA-I(2.2)CAT, respectively, were introduced into human oral epithelial cells (KB), mouse NIH 3T3 cells, Chinese hamster ovary (CHO) cells, human hepatoma cells (Hep G2), human duodenal epithelial cells (Hutu 80), and human colonic epithelial cells (Caco-2) by calcium phosphate coprecipitation. When compared with control vectors, highly efficient CAT expression of both the pA-I(0.6)CAT and pA-I(2.2)CAT constructs were observed only in cells derived from the liver (Hep G2) and intestine (Caco-2), which is consistent with the tissue specificity of expression of the native gene. Analysis of deletion mutants of the human apoA-I 5'-flanking region revealed that: 1) the region from -250 to -199 bp, from -487 to -413 bp, and -1021 to -691 bp upstream from the transcriptional start site contain sequences required for maximum gene expression; and 2) the regions from -2067 to -1476 bp and -199 to -80 bp contain the sequences required for tissue-specific repression of apoA-I gene expression in non-apoA-I producing cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142880

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  FOXO1 and LXRα downregulate the apolipoprotein A-I gene expression during hydrogen peroxide-induced oxidative stress in HepG2 cells.

Authors:  Vladimir S Shavva; Alexandra M Bogomolova; Artemy A Nikitin; Ella B Dizhe; Galina N Oleinikova; Ivan A Lapikov; Dmitry A Tanyanskiy; Andrej P Perevozchikov; Sergey V Orlov
Journal:  Cell Stress Chaperones       Date:  2016-11-28       Impact factor: 3.667

2.  Identification and characterization of new human medium reiteration frequency repeats.

Authors:  J Jurka; D J Kaplan; C H Duncan; J Walichiewicz; A Milosavljevic; G Murali; J F Solus
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

3.  Increased expression of apolipoprotein genes accompanies differentiation in the intestinal cell line Caco-2.

Authors:  S R Reisher; T E Hughes; J M Ordovas; E J Schaefer; S I Feinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

4.  Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells.

Authors:  Lin-Hua Zhang; Vaijinath S Kamanna; Shobha H Ganji; Xi-Ming Xiong; Moti L Kashyap
Journal:  J Lipid Res       Date:  2010-04-06       Impact factor: 5.922

5.  Tumor necrosis factor α stimulates endogenous apolipoprotein A-I expression and secretion by human monocytes and macrophages: role of MAP-kinases, NF-κB, and nuclear receptors PPARα and LXRs.

Authors:  Vladimir S Shavva; Denis A Mogilenko; Ekaterina V Nekrasova; Andrey S Trulioff; Igor V Kudriavtsev; Ekaterina E Larionova; Anna V Babina; Ella B Dizhe; Boris V Missyul; Sergey V Orlov
Journal:  Mol Cell Biochem       Date:  2018-02-13       Impact factor: 3.396

6.  Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4.

Authors:  G S Ginsburg; J Ozer; S K Karathanasis
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Synergistic interactions between transcription factors control expression of the apolipoprotein AI gene in liver cells.

Authors:  R L Widom; J A Ladias; S Kouidou; S K Karathanasis
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

8.  HNF-4 increases activity of the rat Apo A1 gene.

Authors:  J Chan; H Nakabayashi; N C Wong
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

9.  Characterization of genetic markers in the 5'flanking region of the apo A1 gene.

Authors:  C C Shoulders; T M Narcisi; A Jarmuz; D J Brett; J D Bayliss; J Scott
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

10.  Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency.

Authors:  H Akita; H Chiba; M Tsuji; S P Hui; Y Takahashi; K Matsuno; K Kobayashi
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.